Penile Traction Devices
Extenders: Andropenis, PeniMaster PRO, Phallosan Forte, SizeGenetics, RestoreX
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Marketed as devices; RestoreX studied clinically (not FDA-approved for cosmetic enlargement)
Reference only. Not medical advice.
What can go wrong
Generally the lowest-harm method: reported effects are mostly skin irritation, discomfort, temporary numbness, and pinching where the device grips the glans. Serious injury is uncommon with correct use. The main downside is time cost and disappointment relative to marketing. Not a substitute for evaluation when Peyronie's disease or another pathology is present.
This is something to take to a clinician. The Atlas can tell you what is known about penile traction devices in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Penile extenders apply sustained low-force axial traction to the penile shaft, proposed to drive tissue expansion via mechanotransduction (mechanical stretch triggering cellular proliferation and extracellular matrix remodeling). It is the only non-surgical enlargement approach with any RCT support. Reported gains are modest - on the order of ~1-2 cm of flaccid/stretched length over months of daily wear - and the dominant real-world limitation is adherence, because traditional devices require roughly 4-6 hours per day of wear. The strongest evidence is in clinical contexts (Peyronie's disease and pre-prosthesis / post-prostatectomy length preservation) rather than cosmetic enlargement of normal anatomy.
The one non-surgical method with any randomized support - and the gains are still modest.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Sustained tension is thought to activate mechanotransduction pathways - mechanical load sensed by cells triggers proliferation and remodeling of tunica and connective tissue over weeks to months. This is the same biological rationale used in tissue expanders and distraction osteogenesis elsewhere in medicine, and it is why the gains accrue slowly and require consistent daily wear rather than intermittent use.
The adherence catch
The published gains assume a level of daily wear most users never sustain. Traditional extenders demand roughly 4-6 hours per day for months; dropout is high, and gains that depend on cumulative wear-hours quietly evaporate when adherence falls. RestoreX's shorter 30-90 minute protocol is partly a response to this. Even in the best trials, gains are measured as flaccid/stretched length, not spontaneous erect length in men with normal anatomy.
What people get wrong
Often saidExtenders reliably add inches to the erect penis
ActuallyPublished gains are modest (~1-2 cm) and measured as flaccid/stretched length, largely in clinical populations. Brands market this far beyond what the controlled data show.
Often saidA few weeks of wear is enough
ActuallyGains depend on months of consistent daily wear; adherence is the single biggest determinant of whether any change occurs, and dropout is common.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
Device makers profit from a one-time hardware sale plus the aspiration of eventual gains; the low per-unit cost and high margins make aggressive affiliate marketing attractive. Clinicians who use traction for Peyronie's or pre-prosthesis length preservation are a separate, evidence-grounded use case.
Set against the alternatives
Among all non-surgical options, only traction has randomized human data. Vacuum pumps produce temporary engorgement without durable gain; jelqing and hanging have no controlled evidence and higher injury risk; pills have none. Within the category, RestoreX is distinguished by a short daily-use protocol and RCT data in Peyronie's and post-prostatectomy settings, while Andropenis, PeniMaster PRO, Phallosan Forte, and SizeGenetics are consumer brands with longer required wear and mostly manufacturer-associated or small-study evidence.
| Device | Wear pattern | Evidence type | Status |
|---|---|---|---|
| RestoreX | ~30-90 min/session, dynamic | RCTs in Peyronie's & post-prostatectomy | Best-studied; clinician-associated |
| PeniMaster PRO | Several hours/day, vacuum-glans | Small studies; used in Peyronie's series | Consumer/clinical device |
| Phallosan Forte | Long-wear belt system | Manufacturer-associated data | Consumer device |
| Andropenis | ~4-6 h/day, rod extender | Small manufacturer-linked studies | Consumer device |
| SizeGenetics | ~4-6 h/day, rod extender | Marketing-led; limited independent data | Consumer device |
What we do not know
- Does traction produce durable erect-length gain in men with normal anatomy, or only stretched-length change?
- Can shorter dynamic protocols (RestoreX-style) close the adherence gap enough to matter at population scale?
At a glance
- Wear (traditional devices)
- ~4-6 h/day for months
- RestoreX wear
- ~30-90 min/session
- Typical reported gain
- ~1-2 cm flaccid/stretched
- Main failure mode
- Adherence / dropout
- Best-studied context
- Peyronie's disease
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Penile Traction Devices. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Gontero et al., extender in Peyronie's / length2009
Small study showing measurable stretched-length increase with daily traction over months
Ziegelmann et al. (RestoreX RCT, Mayo)2019
Randomized controlled trial: traction improved curvature and length in Peyronie's disease with short daily use
Ziegelmann et al., RestoreX post-prostatectomy RCT2021
Traction improved length and erectile function outcomes after prostatectomy vs control
Systematic review/meta-analysis of traction in Peyronie's2023
Pooled modern-device data: mean length gains ~1.5-2.3 cm with high adherence in clinical protocols